gastric inhibitory peptide target organ pancreatic β-cells - Gastric inhibitory peptidehormone pancreatic β-cells Unraveling the Target Organs of Gastric Inhibitory Peptide (GIP)

Gastric inhibitory peptideother name Gastric inhibitory peptide (GIP), also known as glucose-dependent insulinotropic polypeptide, is a crucial incretin hormone playing a significant role in glucose homeostasis and metabolism. Understanding its target organs is fundamental to comprehending its physiological functions and therapeutic potential. While initially recognized for its effects on gastric secretion, extensive research has revealed a much broader reach for GIP, involving multiple tissues and systems throughout the body.

The primary site of GIP secretion is from enteroendocrine K-cells, which are predominantly located in the duodenum and upper small intestine. These cells are stimulated by the presence of nutrients, particularly carbohydrates and fats, in the intestinal lumen. Upon absorption, GIP enters the bloodstream and exerts its effects by binding to specific GIP receptors (GIPR) found on various cell types.

One of the most well-established target organs for GIP is the pancreas, specifically the pancreatic beta cells. The binding of GIP to its receptors on these cells triggers a cascade of intracellular events, primarily involving an increase in cyclic AMP (cAMP)作者：RG Yip·2000·被引用次数：377—GIPreceptor mRNA is widely distributed in peripheralorgans, including the pancreas, gut, adipose tissue, heart, adrenal cortex, and brain, suggesting it may .... This signaling pathway significantly enhances glucose-stimulated insulin secretion, a process critical for maintaining blood glucose levels within a normal range. This glucose-dependent action of GIP is what defines its role as an incretin hormone. Furthermore, GIP has been shown to inhibit apoptosis and promote proliferation of pancreatic beta cells, contributing to the maintenance of pancreatic beta-cell mass. The insulinotropic effect on pancreatic islet beta-cells is considered a principal physiologic action of GIP.Physiology, Gastric Inhibitory Peptide - StatPearls - NCBI - NIH

Beyond the pancreas, GIP receptors are widely distributed in other peripheral organs and tissues2021年6月27日—Gastric inhibitory peptide(GIP) is best known for its role as an incretin hormone in control of blood glucose concentrations.. Adipose tissue is another significant target organ for GIP. Here, GIP has an anabolic role, promoting the clearance of triglycerides from the circulation and facilitating their storage within adipocytes. This action contributes to energy storage and influences fat metabolism. GIP receptor mRNA is widely distributed in peripheral organs, including the pancreas, gut, adipose tissue, heart, adrenal cortex, and brain, suggesting it may have broader implications than previously understood. The GIP receptor can be found in multiple organs and tissues, reflecting its various physiological functions.

The central nervous system (CNS) is also a notable site where GIP exerts its influence. Research indicates that the GIP receptor is expressed by the brain, and this expression impacts obesity-related pathogenesis.作者：RG Yip·2000·被引用次数：377—GIPreceptor mRNA is widely distributed in peripheralorgans, including the pancreas, gut, adipose tissue, heart, adrenal cortex, and brain, suggesting it may ... Studies have demonstrated that GIP mRNA and protein are expressed in the adult hippocampus, suggesting a role for GIP in brain function. The target organs are not limited to metabolic tissues, as the central nervous system is also a key area of action.

Moreover, GIP receptors have been identified in other tissues, including the heart, pituitary gland, and the inner layers of the adrenal cortex. While the precise functions of GIP in these locations are still under investigation, their presence suggests a more systemic role for this hormone. Some research even indicates that target organs are the central nervous system, respiratory system, kidneys and liver, although the extent of GIP's impact on these organs requires further elucidation.Evidence for beneficial effects of compromised gastric ...

In summary, the gastric inhibitory peptide is a multifaceted hormone with a diverse range of target organsGASTRIC INHIBITORY POLYPEPTIDE IN THE BRAIN. Its primary actions are centered around the pancreatic beta cells for insulin secretion and adipose tissue for lipid metabolism. However, its presence in the brain and other peripheral organs highlights its broader physiological significance, making it a compelling subject for ongoing research in areas such as diabetes, obesity, and potentially even neurodegenerative conditions. The extensive distribution of GIP receptors underscores its importance in maintaining metabolic balance and overall health.